Dorsomorphin (Compound C): Advanced Insights into AMPK and BMP Pathway Inhibition

Introduction

Dorsomorphin, widely recognized as Compound C, stands at the forefront of small-molecule research tools for dissecting cellular energy regulation and differentiation. As a selective ATP-competitive AMPK inhibitor (SKU: B3252), this compound is integral to studies interrogating the AMPK signaling pathway, autophagy, BMP/Smad signaling, and iron metabolism modulation. While previous reviews have detailed its dual-pathway inhibitory action and broad applications, this article provides a distinct, in-depth analysis of Dorsomorphin’s mechanistic nuances, translational applications, and emerging research directions, particularly in light of the latest findings on AMPK regulation in disease models.

Mechanism of Action of Dorsomorphin (Compound C)

AMPK Inhibition: Specificity and Downstream Effects

Dorsomorphin exerts its principal action as a cell-permeable, reversible ATP-competitive inhibitor of AMP-activated protein kinase (AMPK), a master regulator of cellular energy homeostasis. With a Ki of 109 nM, Dorsomorphin offers high selectivity, effectively discriminating AMPK from structurally related kinases such as protein kinase A, protein kinase C, and Janus kinase 3. This specificity allows for precise interrogation of the AMPK signaling pathway without confounding off-target effects.

Upon AMPK inhibition, Dorsomorphin disrupts downstream phosphorylation events—most notably, inhibition of ACC phosphorylation by up to 80% and suppression of autophagic proteolysis. These effects are central to studies on autophagy regulation and metabolic control. In hepatocytes and HeLa cells, Dorsomorphin’s blockade of AMPK leads to reduced fatty acid oxidation and altered metabolic flux, enabling researchers to decouple energetic cues from downstream cellular adaptation.

BMP/Smad Signaling Pathway Blockade

A secondary, yet equally significant, mechanism involves the inhibition of BMP signaling via blockade of Smad 1/5/8 phosphorylation. With an IC50 of 0.47 μM for BMP4-induced SMAD phosphorylation inhibition, Dorsomorphin provides a unique dual-pathway approach, allowing simultaneous dissection of metabolic and differentiation cues. This duality is especially valuable in developmental biology and regenerative medicine, where AMPK and BMP/Smad pathways intersect to regulate stem cell fate and tissue morphogenesis.

Modulation of Iron Metabolism

Through BMP pathway inhibition, Dorsomorphin also reduces hepatic hepcidin gene transcription, resulting in increased serum iron. This property has been harnessed in animal models to investigate iron metabolism modulation and the interplay between systemic iron homeostasis and cellular signaling.

Scientific Context: AMPK in Disease and Immunometabolism

The role of AMPK extends far beyond energy sensing, with emerging evidence implicating AMPK in immune modulation, inflammation, and chronic diseases. A pivotal study by Lei et al. (2025, Inflammation) elucidated that downregulation of AMPK in macrophages promotes M1 polarization, driving pro-inflammatory responses in obesity-related asthma. Activation of AMPK was shown to attenuate airway inflammation through the JAK2/STAT3 pathway, highlighting the therapeutic potential of targeting AMPK in metabolic and inflammatory diseases. This mechanistic insight underscores Dorsomorphin’s value—not only as a research tool but also as a probe for dissecting disease-relevant signaling networks.

Comparative Analysis with Alternative Methods and Tools

Existing reviews, such as those at Compound-56 and ALK-1, have extensively characterized Dorsomorphin as a dual-pathway inhibitor for autophagy, metabolic, and differentiation research. However, these works often focus on broad, translational applications or the competitive positioning of Dorsomorphin versus other inhibitors. This article differentiates itself by delving into the interplay between AMPK inhibition, immune cell polarization, and iron metabolism—a perspective rarely addressed in prior content.

Alternative AMPK inhibitors, such as SBI-0206965 or A-769662, differ mechanistically; some target upstream kinases or induce allosteric effects rather than competing for ATP binding. While these alternatives provide valuable tools for pathway dissection, Dorsomorphin’s ATP-competitive, reversible inhibition ensures rapid, tunable, and highly specific modulation—ideal for acute experiments requiring temporal control. Moreover, its dual action on BMP/Smad signaling distinguishes it from single-pathway modulators.

Advanced Applications of Dorsomorphin (Compound C)

1. Dissecting Immune Regulation and Inflammation

The inhibition of AMPK activity in hepatocytes and immune cells using Dorsomorphin enables the study of metabolic-immune cross-talk. Building upon the findings from Lei et al., researchers can use Dorsomorphin to model the consequences of AMPK suppression on macrophage polarization, inflammation, and metabolic imbalance. This is critical for understanding diseases like obesity-related asthma, type 2 diabetes, and chronic inflammatory syndromes.

2. Autophagy Regulation and Metabolic Research

Dorsomorphin’s ability to suppress AMPK-driven autophagic flux has made it invaluable for investigating the relationship between energy stress and cellular recycling. Unlike single-pathway reviews—such as those in previous articles focusing on mitophagy and muscle atrophy—this article emphasizes the emerging role of autophagy in immune modulation and metabolic adaptation, providing a broader systems-biology context.

3. Neural Stem Cell Differentiation and Regenerative Medicine

By blocking BMP signaling, Dorsomorphin promotes self-renewal and neural induction in human embryonic stem cells. This property is leveraged in protocols for generating neural progenitors and modeling neurodevelopmental processes. In contrast to existing overviews that highlight general differentiation effects, this article explores how combinatorial AMPK and BMP inhibition influences lineage specification, neural patterning, and potential applications in disease modeling.

4. Iron Metabolism and Hepcidin Regulation

Dorsomorphin’s suppression of hepatic hepcidin transcription, and resultant increase in serum iron, supports the study of iron overload disorders, anemia of inflammation, and systemic metabolic interactions. This dual capacity to modulate both metabolic signaling and iron homeostasis is unique among small-molecule inhibitors, as previously noted in comparative reviews—but here, we integrate the implications for immunometabolism and chronic disease.

Experimental Considerations and Best Practices

Dorsomorphin is supplied as a solid by APExBIO (Dorsomorphin (Compound C)), with recommended storage at –20°C. The compound is insoluble in water and ethanol, but readily dissolves in DMSO at concentrations ≥8.49 mg/mL when gently warmed and sonicated. For optimal results, solutions should be freshly prepared and used promptly, as long-term storage is not advised.

Typical experimental concentrations range from 4 to 40 μM for cell culture studies and up to 10 mg/kg via intraperitoneal injection in animal models. Researchers are advised to titrate doses according to cell type, readout, and desired temporal resolution. In zebrafish and other model organisms, Dorsomorphin serves as a robust tool for inducing dorsalization and studying morphogen gradients.

Integration with Broader Research and Content Landscape

Whereas previous articles—such as this primer on dual-pathway inhibition—primarily catalog Dorsomorphin’s established applications in metabolic and differentiation research, this article advances the discourse by integrating new findings on AMPK’s role in immune cell polarization and iron metabolism. By situating Dorsomorphin within the context of immunometabolism and chronic disease, this piece provides a more holistic, translational framework for future investigations.

Notably, unlike the strategic guidance articles that emphasize product positioning, the present work is anchored in mechanistic depth and scientific synthesis, offering conceptual clarity for researchers designing experiments at the intersection of metabolism, immunity, and development.

Conclusion and Future Outlook

Dorsomorphin (Compound C) remains an indispensable tool for probing the intersections of energy metabolism, autophagy regulation, BMP/Smad signaling, and iron metabolism modulation. Its unique capacity for selective, ATP-competitive AMPK inhibition and BMP pathway blockade enables advanced experimental designs that unravel the complex web of cellular communication. The integration of recent discoveries—such as the JAK2/STAT3-mediated effects of AMPK on macrophage polarization (Lei et al., 2025)—opens new avenues for Dorsomorphin in immunometabolic research and precision medicine.

For researchers seeking a rigorously characterized, multifaceted inhibitor, Dorsomorphin (Compound C) from APExBIO offers a gold standard for dissecting the molecular choreography that underpins health and disease. As our understanding of metabolic-immune interplay deepens, Dorsomorphin’s relevance will only expand—underscoring its pivotal role in next-generation biomedical research.